NIMH funds clinical research to improve Schizophrenia treatment
The NIMH-funded Schizophrenia clinical research is led by John Kane, a schizophrenia researcher and Feinstein Institutes professor. Credit: PRNewsfoto.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more